← Eichor
Study identifier: NCT05852314 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Problem-Solving Intervention for Women With Suicidal Ideation During Postnatal Period in Pakistan

Condition: Postnatal Depression  ·  Sponsor: Pakistan Institute of Living and Learning

PhaseNA
Planned participants90
Who can joinFemale, 16 Years to 44 Years
Healthy volunteersNo

About this study

The aim of this study is to determine the feasibility and acceptability of culturally adapted CMAP for suicidal Ideation for women in postnatal period. Objectives 1. To adapt existing CMAP Intervention for suicidal ideation (CMAP-SI) in postnatal period. 2. To investigate whether CMAP-SI is feasible and acceptable among women presenting suicidal Ideations in postnatal period; and 3. To test whether there is an indication for the effects of the CMAP in reducing suicidal thoughts among women in postnatal period. 4. To explore participants experiences with CMAP-SI Intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Tayyaba Kiran, PhD.  ·  021-35871845  ·  tayyaba.kiran@pill.org.pk

Rabia Sattar, PhD. Cont.  ·  04237881614  ·  rabia.sattar@pill.org.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Benazir Bhutto HospitalRawalpindi, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05852314